top of page

​

coprinus-micaceus-mushroom-coprinus-atramentarius-2023-11-27-05-30-04-utc-2880x1800.jpg
Psilocybin has been designated a breakthrough therapy by the FDA. While research on the therapeutic effects of psilocybin is still in its early stages, there is growing evidence suggesting its potential benefits for various conditions. Here are some conditions that the research has explored:
depression icon
Depression

Some studies report that psilocybin, when administered with psychological support, may have rapid and sustained antidepressant effects in individuals with treatment-resistant depression (those who do not respond to traditional treatments/medications).

anxiety icon
Anxiety

Psilocybin has shown promise in alleviating symptoms of anxiety in certain individuals. Research is ongoing to explore its potential in conditions such as generalized anxiety disorder and social anxiety.

headache icon
Post Traumatic Stress Disorder (PTSD)

Psilocybin-assisted treatment is being investigated for PTSD in helping individuals process traumatic experiences.

Addiction

Research indicates that psilocybin may be beneficial in treating various forms of addiction, including alcohol and tobacco dependence. It is thought to work by disrupting entrenched patterns of thought and behavior.

enlightenment icon
Cognitive Enhancement

Some studies suggest that psilocybin may have the potential to enhance creativity, problem-solving skills, and cognitive flexibility.

distress icon
Terminal Illness

Psilocybin-assisted therapy has been explored as a way to provide emotional and psychological support for individuals facing terminal illnesses, helping them cope with anxiety and existential distress.

bottom of page